James I. Merlino, MD Department of Surgery, MetroHealth Medical Center, Cleveland, OH; Case Western Reserve University School of Medicine, Cleveland, OH
Mark A. Malangoni, MD Chair and Surgeon-in-Chief, Department of Surgery, MetroHealth Medical Center, Cleveland, OH; Case Western Reserve University School of Medicine, Cleveland, OH
Correspondence: Mark A. Malangoni, MD, Chair, Department of Surgery and Surgeon-in-Chief, MetroHealth Medical Center, 2500 MetroHealth Drive, H 914A, Cleveland, OH 44109–1998; mmalangoni@metrohealth.org
Both authors reported that they have received honoraria from Wyeth Pharmaceuticals for writing or speaking, and Dr. Malangoni reported that he has received research grant support from Wyeth.
The authors reported that they prepared this article without assistance from any medical education company.
ABSTRACT
Skin and soft-tissue infections are common and generally are uncomplicated at the time of initial presentation. However, these infections can worsen quickly when there are delays in presentation and treatment. Upon encountering these infections, physicians must respond quickly with an appropriate therapeutic plan and be aware of trends in microbial resistance in order to optimize patient care.
